Common Contracts
2 similar License Agreement contracts by Emergent BioSolutions Inc., Opiant Pharmaceuticals, Inc.
AMENDMENT NO. 2 TO LICENSE AGREEMENTLicense Agreement • May 8th, 2019 • Emergent BioSolutions Inc. • Pharmaceutical preparations
This Amendment No. 2 to License Agreement (this “Amendment”) is made as of March 18, 2019, by and between Opiant Pharmaceuticals Inc. (formerly known as Lightlake Therapeutics Inc.), a Delaware corporation (“Opiant”), and Adapt Pharma Operations Limited, an Irish limited company (“Adapt”). Opiant and Adapt are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Capitalized terms used but not defined herein have the meanings given to them in the License Agreement (as defined below).
AMENDMENT NO. 2 TO LICENSE AGREEMENTLicense Agreement • March 21st, 2019 • Opiant Pharmaceuticals, Inc. • Metal mining
This Amendment No. 2 to License Agreement (this “Amendment”) is made as of March 18, 2019, by and between Opiant Pharmaceuticals Inc. (formerly known as Lightlake Therapeutics Inc.), a Delaware corporation (“Opiant”), and Adapt Pharma Operations Limited, an Irish limited company (“Adapt”). Opiant and Adapt are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Capitalized terms used but not defined herein have the meanings given to them in the License Agreement (as defined below).
